Lee, Seung Hun
Lee, Jee Yang
Lim, Kyeong-Hye
Lee, Young-Sun
Kim, Seong-Hee
Choi, Sooyoung
Cho, Seong-Hwan
Koh, Jung-Min http://orcid.org/0000-0002-7987-3677
Funding for this research was provided by:
Ministry of Health and Welfare (HI15C0377)
Asan Institute for Life Sciences, Asan Medical Center (2019IP0862)
Article History
Received: 21 April 2020
Accepted: 14 July 2020
First Online: 27 July 2020
Compliance with Ethical Standards
:
: Seong-Hee Kim, Sooyoung Choi, and Seong-Hwan Cho have patents registered in Korea (KR 10-1486368) and patent applications in the USA (US 15/927,459) for sphingosine-1-phosphate. They provided the S1P ELISA kits, but were not involved in the design and conduct of the study (i.e. the management, analysis, and interpretation of the data). Seung Hun Lee, Jee Yang Lee, Kyeong-Hye Lim, Young-Sun Lee, and Jung-Min Koh state that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Asan Medical Center Ethics Review Committee (2018–0556).
: Written informed consent was obtained from all study subjects.